Foster, Amanda A.
Stoll, Jennifer
Daly, Christopher J.
Clark, Collin M.
Sethi, Sanjay
Jacobs, David M.
Funding for this research was provided by:
Theravance Biopharma US
Viatris
Article History
Received: 15 May 2023
Accepted: 11 September 2023
First Online: 23 September 2023
Declarations
:
: The study was conducted in accordance with the principles of the Helsinki Declaration and the University at Buffalo Institutional Review Board (IRB Protocol #3792) approved the study protocol. Participants were informed about the topics of the interview, voluntary participation and that interviews would be recorded and later analyzed. All participants provided informed consent to participate in the study.
: Not applicable.
: The authors declare no competing interests.